SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-015755
Filing Date
2023-09-14
Accepted
2023-09-14 16:22:42
Documents
89
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-K rzlt-20230630x10k.htm   iXBRL 10-K 2243882
2 EX-4 rzlt-20230630xex4.htm EX-4 57453
3 EX-21.1 rzlt-20230630xex21d1.htm EX-21.1 7926
4 EX-23.1 rzlt-20230630xex23d1.htm EX-23.1 2672
5 EX-31.1 rzlt-20230630xex31d1.htm EX-31.1 18772
6 EX-32.1 rzlt-20230630xex32d1.htm EX-32.1 9373
  Complete submission text file 0001558370-23-015755.txt   9332385

Data Files

Seq Description Document Type Size
7 EX-101.SCH rzlt-20230630.xsd EX-101.SCH 73907
8 EX-101.CAL rzlt-20230630_cal.xml EX-101.CAL 55961
9 EX-101.DEF rzlt-20230630_def.xml EX-101.DEF 338274
10 EX-101.LAB rzlt-20230630_lab.xml EX-101.LAB 505390
11 EX-101.PRE rzlt-20230630_pre.xml EX-101.PRE 515075
83 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20230630x10k_htm.xml XML 1406207
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39683 | Film No.: 231255334
SIC: 2834 Pharmaceutical Preparations